Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03800836
Title A Study to Evaluate the Safety and Efficacy of Ipatasertib in Combination With Atezolizumab and Paclitaxel or Nab-Paclitaxel in Participants With Locally Advanced or Metastatic Triple-Negative Breast Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Hoffmann-La Roche
Indications

triple-receptor negative breast cancer

Therapies

Atezolizumab + Ipatasertib + Paclitaxel

Atezolizumab + Ipatasertib + Nab-paclitaxel

Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Pacific Shores Medical Group Long Beach California 90813 United States Details
St Vincents Hospital; Cardiopulmonary transplant Ambulatory Care Dept Darlinghurst New South Wales 2010 Australia Details
Peter MacCallum Cancer Center East Melbourne Victoria 3002 Australia Details
Austin Hospital Heidelberg Victoria 3084 Australia Details
Institut de Cancerologie de l Ouest Angers 49055 France Details
Institut Bergonie Bordeaux 33076 France Details
Centre Georges Francois Leclerc Dijon 21000 France Details
Institut Curie Paris 75005 France Details
Gustave Roussy Villejuif CEDEX 94800 France Details
Hospital de la Santa Creu i Sant Pau Barcelona 08025 Spain Details
Hospital Universitario La Paz Madrid 280146 Spain Details
Hospital Clinico San Carlos; Servicio de Oncologia Madrid 28040 Spain Details
Hospital Universitario Fundacion Jimenez Diaz. Madrid 28040 Spain Details
Hospital Universitario 12 de Octubre Madrid 28041 Spain Details
Centro Integral Oncologico Clara Campal (CIOCC); Dirección Médica Madrid 28050 Spain Details
Hospital Universitario Virgen del Rocío Sevilla 41013 Spain Details
Barts Cancer Institute London E1 2AT United Kingdom Details
Nottingham University Hospitals NHS Trust Nottingham NG7 2UH United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field